Dermatology news

Emollients, Potential Skin Sensitisers as Ingredients

Emollients, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in emollient preparations.

Topical Steroids, Comparison of Potencies and Formulations

Topical Steroids, Comparison of Potencies and Formulations

Strengths and formulations of topical steroids.

Topical Steroids, Potential Skin Sensitisers as Ingredients

Topical Steroids, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in topical steroids.

Doctors identify 50 'unnecessary' medical interventions

Doctors identify 50 'unnecessary' medical interventions

A list of 50 tests, treatments and procedures 'of questionable...

NICE approves guselkumab for plaque psoriasis

NICE approves guselkumab for plaque psoriasis

Guselkumab (Tremfya) is now an option for routine NHS...

Emollient bath additives 'no benefit' in childhood eczema

Emollient bath additives 'no benefit' in childhood eczema

Emollient bath additives provide no clinical benefit...

Psoriasis biologic approved for NHS prescribing

Psoriasis biologic approved for NHS prescribing

Brodalumab (Kyntheum) can now be prescribed routinely...

Dupilumab: first biologic for moderate-to-severe atopic dermatitis

Dupilumab: first biologic for moderate-to-severe atopic dermatitis

Dupilumab (Dupixent) is the first biologic treatment...

Guselkumab further extends choice in psoriasis prescribing

Guselkumab further extends choice in psoriasis prescribing

Tremfya (guselkumab) is licensed for the treatment...

NICE approval for new psoriasis tablet

NICE approval for new psoriasis tablet

Dimethyl fumarate (Skilarence) is now an option for...

Topical psoriasis treatment to be available without a prescription

Topical psoriasis treatment to be available without a prescription

Patients with psoriasis will be able to buy Dovonex...

Fumaric acid ester now available as licensed oral psoriasis treatment

Fumaric acid ester now available as licensed oral psoriasis treatment

Prescribers treating patients with moderate to severe...

Brodalumab: a new biologic for moderate-to-severe plaque psoriasis

Brodalumab: a new biologic for moderate-to-severe plaque psoriasis

Kyntheum (brodalumab) injection is now available for...

Cardiovascular warning for rosacea gel

Cardiovascular warning for rosacea gel

Patients using the topical rosacea treatment brimonidine...

NHS approval for latest psoriasis biologic

NHS approval for latest psoriasis biologic

NICE has recommended ixekizumab (Taltz) as an option...

Psychiatric advice issued for psoriasis treatment

Psychiatric advice issued for psoriasis treatment

The prescribing information for apremilast (Otezla)...

NICE approves apremilast for refractory psoriasis

NICE approves apremilast for refractory psoriasis

In new guidance NICE recommends the use of apremilast...

Start brimonidine gel at low dose in rosacea, cautions MHRA

Start brimonidine gel at low dose in rosacea, cautions MHRA

Treatment with the topical rosacea treatment brimonidine...

Hidradenitis suppurativa treatment accepted for NHS use

Hidradenitis suppurativa treatment accepted for NHS use

Adalimumab (Humira) has been approved by NICE for patients...

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more